NOW Aktie
WKN DE: A113R6 / ISIN: US67011P1003
10.06.2024 11:50:00
|
Why Moderna Stock Is a No-Brainer Buy Right Now
Some investors might view Moderna (NASDAQ: MRNA) as a shooting star that shined bright for a while then flamed out. In 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only $4 billion this year.The real story for Moderna is much better than that steep sales decline reflects. Here's why the biotech stock is a no-brainer buy right now.It's no exaggeration to say that Moderna is at an inflection point. The company's previous success stemmed entirely from its COVID-19 vaccine Spikevax. That's changing.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu NOW Inc When Issuedmehr Nachrichten
Analysen zu NOW Inc When Issuedmehr Analysen
Aktien in diesem Artikel
Moderna Inc | 24,02 | -6,04% |
|
NOW Inc When Issued | 15,30 | -3,77% |
|